ReviewVaccines2015
Emerging Vaccine Technologies.
Review in Vaccines, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Design of a novel proteome-derived scaffold presenting epitopes of Pseudomonas aeruginosa in native conformation.Scientific reports · 2026Article
- Review
- Immunogenicity of HIV-1Vaccines · 2025Article
- Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview.Heliyon · 2024Review
- Potential Application of Exosomes in Vaccine Development and Delivery.Pharmaceutical research · 2022Review
- Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies.NPJ vaccines · 2022Review
- Moving beyond Titers.Vaccines · 2022Review
- Review
- High-throughput Sequencing in Vaccine Research.Journal of veterinary research · 2021Article
- Comparison of regulatory framework of clinical trial with genetically modified organism-containing vaccines in the Europe, Australia, and Switzerland.Clinical and experimental vaccine research · 2021Review
- In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives.Advanced drug delivery reviews · 2021Review
- Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production.Vaccines · 2021Review
- Temperature effect on the SARS-CoV-2: A molecular dynamics study of the spike homotrimeric glycoprotein.Computational and structural biotechnology journal · 2021Article
- Optimizing Anti-Viral Vaccine Responses: Input from a Non-Specialist.Antibiotics (Basel, Switzerland) · 2020Article
- Antibodies, synthetic peptides and related constructs for planetary health based on green chemistry in the Anthropocene.Future science OA · 2018Review
- New Vaccine Technologies to Combat Outbreak Situations.Frontiers in immunology · 2018Review
- Article
- Vectored immunoprophylaxis: an emerging adjunct to traditional vaccination.Tropical diseases, travel medicine and vaccines · 2017Review
- Vaccination to gain humoral immune memory.Clinical & translational immunology · 2016Review
- Successful completion of a semi-automated enzyme-free cloning method.Journal of structural and functional genomics · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emergence of new technologies with a growing understanding of host-pathogen interactions and immunity may lead to efficacious vaccines against pathogens, previously thought impossible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.